Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
BRL-101 by BRL Medicine for Sickle Cell Disease: Likelihood of Approval
BRL-101 is under clinical development by BRL Medicine and currently in Phase II for Sickle Cell Disease. According to GlobalData,...